Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CIPC is an acronym that refers to several distinct entities. In the context of a chemical substance, CIPC stands for chlorpropham, also known as isopropyl N-(3-chlorophenyl) carbamate. This small molecule functions as a sprout suppressant, primarily used in the agricultural industry to prevent the premature growth of buds on potato tubers during storage, thereby reducing wastage and ensuring year-round availability. Its mechanism of action involves interfering with the cell division machinery, potentially by targeting a component of the augmin complex, which is crucial for mitosis. While widely used globally, chlorpropham has faced increasing regulatory scrutiny, including a ban in the European Union since 2020, due to concerns about its toxicity and residue in commodities, prompting research into alternative sprout suppressants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorpropham.